Literature DB >> 15458926

NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene.

Hua Xu1, Jennifer K Uno, Michael Inouye, James F Collins, Fayez K Ghishan.   

Abstract

The human intestinal type IIb Na+-P(i) cotransporter (hNaPi-IIb) gene promoter lacks a TATA box and has a high GC content in the 5'-flanking region. To understand the mechanism of hNaPi-IIb gene transcription, the current study was performed to characterize the minimal promoter region and transcriptional factor(s) necessary to activate gene expression in human intestinal cells (Caco-2). With the use of progressively shorter promoter constructs, a minimal promoter extending from bp -58 to +15 was identified and shown to direct high levels of hNaPi-IIb cotransporter expression in Caco-2 cells. Gel mobility shift assays (GMSAs) indicated that two regions could be bound by nuclear proteins from Caco-2 cells: region A at bp -26/-23 and region B at bp -44/-35. The introduction of mutations in region A abolished promoter activity, whereas mutations in region B had no effect. Deletion mutants of the same regions showed identical results. Furthermore, DNase I footprinting experiments confirmed the observation made by GMSAs. Additional studies, which used a specific nuclear factor 1 (NF1) antiserum, demonstrated that NF1 protein(s) binds to the minimal promoter at region A. These results indicated that the NF1 protein(s) is required to activate the basal transcription of hNaPi-IIb gene under normal growth conditions. This study has thus identified a new target gene in the small intestinal epithelium that is directly regulated by NF1 transcriptional factor(s).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458926     DOI: 10.1152/ajpgi.00396.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  All-trans retinoic acid reduces the transcriptional regulation of intestinal sodium-dependent phosphate co-transporter gene (Npt2b).

Authors:  Masashi Masuda; Hironori Yamamoto; Yuichiro Takei; Otoki Nakahashi; Yuichiro Adachi; Kohta Ohnishi; Hirokazu Ohminami; Hisami Yamanaka-Okumura; Hiroshi Sakaue; Makoto Miyazaki; Eiji Takeda; Yutaka Taketani
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

2.  Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.

Authors:  Ayse Corut; Abdurrahman Senyigit; Sibel Aylin Ugur; Sedat Altin; Ugur Ozcelik; Haluk Calisir; Zeki Yildirim; Ayhan Gocmen; Aslihan Tolun
Journal:  Am J Hum Genet       Date:  2006-08-29       Impact factor: 11.025

3.  Nuclear factor I X deficiency causes brain malformation and severe skeletal defects.

Authors:  Katrin Driller; Axel Pagenstecher; Markus Uhl; Heymut Omran; Ansgar Berlis; Albert Gründer; Albrecht E Sippel
Journal:  Mol Cell Biol       Date:  2007-05       Impact factor: 4.272

4.  Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis.

Authors:  Huacong Chen; Hua Xu; Jiali Dong; Jing Li; Fayez K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-05       Impact factor: 4.052

5.  Nfix Regulates Temporal Progression of Muscle Regeneration through Modulation of Myostatin Expression.

Authors:  Giuliana Rossi; Stefania Antonini; Chiara Bonfanti; Stefania Monteverde; Chiara Vezzali; Shahragim Tajbakhsh; Giulio Cossu; Graziella Messina
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

6.  Construction of an integrative regulatory element and variation map of the murine Tst locus.

Authors:  Jasmina Beltram; Nicholas M Morton; Tanja Kunej; Simon Horvat
Journal:  BMC Genet       Date:  2016-06-11       Impact factor: 2.797

7.  Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration.

Authors:  Giuliana Rossi; Chiara Bonfanti; Stefania Antonini; Mattia Bastoni; Stefania Monteverde; Anna Innocenzi; Marielle Saclier; Valentina Taglietti; Graziella Messina
Journal:  Nat Commun       Date:  2017-10-20       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.